Bochner, Bernard

Publications

Sort by

Co-Author Network

selected publications

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort^†: Under the Auspices of the EAU-ESMO Guidelines Committees. European urology. 2019 Conference Paper GET IT
Times cited: 117
A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy. Urology. 2019 Academic Article GET IT
Times cited: 26
Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails. European urology. 2019 Editorial Article GET IT
Times cited: 1
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies. The American journal of surgical pathology. 2019 Academic Article GET IT
Times cited: 50
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. The Journal of pathology. 2019 Academic Article GET IT
Times cited: 28
A Thoughtful Pause for Sparing Oophorectomy. Urology. 2019 Letter GET IT
Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2019 Academic Article GET IT
Times cited: 34
Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?. European urology. 2019 Letter GET IT
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 130
Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. European urology. 2018 Academic Article GET IT
Times cited: 173
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 94
Male Neobladder. The Urologic clinics of North America. 2018 Review GET IT
Times cited: 5
Postchemotherapy Surgery for Advanced Urothelial Cancer: Another Tool To Improve Outcome. European urology. 2017 Editorial Article GET IT
Times cited: 1
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 67
Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. European urology. 2017 Academic Article GET IT
Times cited: 217
Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin. Cancer cytopathology. 2017 Academic Article GET IT
Times cited: 24
A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer. Urology. 2016 Academic Article GET IT
Times cited: 39
Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma who have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicenter, Phase 2 Trial. European urology. 2016 Comment GET IT
Times cited: 3
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy. European urology. 2016 Review GET IT
Times cited: 61
Genomic characterization of response to chemoradiation in urothelial bladder cancer. Cancer. 2016 Academic Article GET IT
Times cited: 46
Parastomal hernias after radical cystectomy and ileal conduit diversion. Investigative and clinical urology. 2016 Review GET IT
Times cited: 23
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World journal of urology. 2016 Review GET IT
Times cited: 20
A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor. The Journal of urology. 2016 Academic Article GET IT
Times cited: 36
Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes, Key Elements, and Research Needs. European urology. 2016 Review GET IT
Times cited: 193
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nature genetics. 2016 Academic Article GET IT
Times cited: 118
Rationale and Early Experience with Prophylactic Placement of Mesh to Prevent Parastomal Hernia Formation after Ileal Conduit Urinary Diversion and Cystectomy for Bladder Cancer. Current urology reports. 2016 Review GET IT
Times cited: 24
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma. The Journal of urology. 2016 Academic Article GET IT
Times cited: 32
Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center. European urology focus. 2015 Academic Article GET IT
Times cited: 8
Idiographic quality of life assessment before radical cystectomy. Psycho-oncology. 2015 Academic Article GET IT
Times cited: 7
Genomic Characterization of Upper Tract Urothelial Carcinoma. European urology. 2015 Academic Article GET IT
Times cited: 165
Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review. Urologic oncology. 2015 Review GET IT
Times cited: 12
Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?. The Urologic clinics of North America. 2015 Review GET IT
Times cited: 5
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. European urology. 2015 Review GET IT
Times cited: 205
Re: whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. European urology. 2015 Comment GET IT
Times cited: 2
Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway. Urology. 2015 Academic Article GET IT
Times cited: 22
Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. European urology. 2015 Conference Paper GET IT
Times cited: 150
Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. European urology. 2015 Review GET IT
Times cited: 180
Comparison of perioperative outcomes for epidural versus intravenous patient-controlled analgesia after radical cystectomy. Regional anesthesia and pain medicine. 2015 Academic Article GET IT
Times cited: 21
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. European urology. 2014 Academic Article GET IT
Times cited: 434
More on robot-assisted laparoscopic radical cystectomy. The New England journal of medicine. 2014 Letter GET IT
Times cited: 1
Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes. Clinical imaging. 2014 Academic Article GET IT
Times cited: 14
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nature reviews. Urology. 2014 Review GET IT
Times cited: 53
Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 23
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer discovery. 2014 Academic Article GET IT
Times cited: 438
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder. European urology. 2014 Academic Article GET IT
Times cited: 110
A randomized trial of robot-assisted laparoscopic radical cystectomy. The New England journal of medicine. 2014 Letter GET IT
Times cited: 80
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. Cancer discovery. 2014 Academic Article GET IT
Times cited: 97
Adherence to surveillance guidelines after radical cystectomy: a population-based analysis. Urologic oncology. 2014 Academic Article GET IT
Times cited: 10
Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions. Advances in urology. 2014 Academic Article GET IT
Times cited: 39
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States. Urologic oncology. 2014 Academic Article GET IT
Times cited: 41
The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder. Urologic oncology. 2014 Academic Article GET IT
Times cited: 19
Prospective evaluation of plasma kinetic bipolar resection of bladder cancer: comparison to monopolar resection and pathologic findings. International urology and nephrology. 2014 Academic Article GET IT
Times cited: 28
Aminopeptidase activities as prospective urinary biomarkers for bladder cancer. Proteomics. Clinical applications. 2014 Academic Article GET IT
Times cited: 9
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. The Journal of urology. 2014 Academic Article GET IT
Times cited: 59
The mechanism of action of BCG therapy for bladder cancer--a current perspective. Nature reviews. Urology. 2014 Review GET IT
Times cited: 453
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 48
Editorial comment. Urology. 2014 Comment GET IT
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Academic Article GET IT
Times cited: 2179
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU international. 2014 Review GET IT
Times cited: 233
Risk factors for the development of parastomal hernia after radical cystectomy. The Journal of urology. 2013 Academic Article GET IT
Times cited: 55
Does minimally invasive surgery for radical cystectomy provide similar long-term cancer control as open radical surgery?. Current opinion in urology. 2013 Review GET IT
Times cited: 7
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 240
The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology. 2013 Academic Article GET IT
Times cited: 22
Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 32
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure. The Journal of urology. 2013 Academic Article GET IT
Times cited: 35
Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique. Transplantation proceedings. 2013 Academic Article GET IT
Times cited: 8
Lymphadenectomy for bladder cancer at the time of radical cystectomy. European urology. 2013 Review GET IT
Times cited: 46
Oncologic outcomes achieved by radical cystectomy. European urology. 2013 Editorial Article GET IT
Times cited: 3
Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 71
A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 37
Urinary diversion practice patterns among certifying American urologists. The Journal of urology. 2012 Academic Article GET IT
Times cited: 13
Genome sequencing identifies a basis for everolimus sensitivity. Science (New York, N.Y.). 2012 Academic Article GET IT
Times cited: 578
ICUD-EAU International Consultation on Bladder Cancer 2012: Urothelial carcinoma of the prostate. European urology. 2012 Conference Paper GET IT
Times cited: 21
Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. European journal of radiology. 2012 Academic Article GET IT
Times cited: 55
Technical advances in bladder cancer patient care: progress or promise?. European urology. 2012 Editorial Article GET IT
Times cited: 3
Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer. 2012 Academic Article GET IT
Times cited: 26
Pubovesical fistula: a rare complication after treatment of prostate cancer. Urology. 2012 Academic Article GET IT
Times cited: 42
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. European urology. 2012 Review GET IT
Times cited: 185
Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU international. 2012 Academic Article GET IT
Times cited: 23
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 14
Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer. Molecular imaging and biology. 2012 Academic Article GET IT
Times cited: 47
Re: "Pelvic exenteration with curative intent for recurrent uterine malignancies". Gynecologic oncology. 2012 Letter GET IT
Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. European urology. 2012 Academic Article GET IT
Times cited: 85
Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic research. Urologic oncology. 2012 Review GET IT
Times cited: 5
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 30
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 149
Bladder cancer treatment: optimize, don't compromise. Oncology (Williston Park, N.Y.). 2011 Comment GET IT
Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 62
Bladder cancer imaging: an update. Current opinion in urology. 2011 Review GET IT
Times cited: 9
MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. Clinical radiology. 2011 Academic Article GET IT
Times cited: 19
Chemotherapy: Standardizing the care of invasive bladder cancer. Nature reviews. Clinical oncology. 2011 Article GET IT
Times cited: 1
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU international. 2011 Academic Article GET IT
Times cited: 153
The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. European urology. 2011 Review GET IT
Times cited: 126
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma. The Journal of pathology. 2011 Academic Article GET IT
Times cited: 71
A plea for a uniform surveillance schedule after radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 11
The psychological context of quality of life: a psychometric analysis of a novel idiographic measure of bladder cancer patients' personal goals and concerns prior to surgery. Health and quality of life outcomes. 2011 Academic Article GET IT
Times cited: 25
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy. BJU international. 2011 Academic Article GET IT
Times cited: 12
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU international. 2010 Academic Article GET IT
Times cited: 13
Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?. European urology. 2010 Academic Article GET IT
Times cited: 95
The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. European urology. 2010 Academic Article GET IT
Times cited: 141
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. The Journal of urology. 2010 Academic Article GET IT
Times cited: 46
Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. European urology. 2010 Academic Article GET IT
Times cited: 192
Clinical outcome of primary versus secondary bladder carcinoma in situ. The Journal of urology. 2010 Academic Article GET IT
Times cited: 34
Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2010 Academic Article GET IT
Times cited: 36
Editorial comment. Urology. 2010 Editorial Article GET IT
Times cited: 1
A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution?. European urology. 2010 Review GET IT
Times cited: 54
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 22
Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches. The Journal of urology. 2010 Review GET IT
Times cited: 71
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer. Urologic oncology. 2010 Conference Paper GET IT
Times cited: 3
Overview of SUO Winter 2008 proceedings. Urologic oncology. 2010 Article GET IT
Words of wisdom. Re: Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. European urology. 2010 Comment GET IT
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer. 2009 Academic Article GET IT
Times cited: 26
The effect of age and gender on bladder cancer: a critical review of the literature. BJU international. 2009 Review GET IT
Times cited: 233
Bladder cancer: narrowing the gap between evidence and practice. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 44
Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients. The Journal of urology. 2009 Academic Article GET IT
Times cited: 8
Imaging: does DW-MRI have a role in the evaluation of hematuria?. Nature reviews. Urology. 2009 Article GET IT
Times cited: 1
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. European urology. 2009 Academic Article GET IT
Times cited: 107
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas. Oncogene. 2009 Academic Article GET IT
Times cited: 52
Optimal timing of radical cystectomy for patients with T1 bladder cancer. Urologic oncology. 2009 Review GET IT
Times cited: 16
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer. 2008 Academic Article GET IT
Times cited: 219
Gene therapy in bladder cancer. Current opinion in urology. 2008 Review GET IT
Times cited: 16
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European urology. 2008 Academic Article GET IT
Times cited: 1043
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. European urology. 2008 Academic Article GET IT
Times cited: 192
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008 Academic Article GET IT
Times cited: 241
Bladder cancer: can imaging change patient management?. Current opinion in urology. 2008 Review GET IT
Times cited: 32
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2007 Academic Article GET IT
Times cited: 32
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. The Journal of urology. 2007 Academic Article GET IT
Times cited: 73
Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression. The American journal of pathology. 2007 Academic Article GET IT
Times cited: 28
Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 23
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. European urology. 2007 Academic Article GET IT
Times cited: 89
Prognostic significance of p27Kip1 expression in bladder cancer. BJU international. 2007 Academic Article GET IT
Times cited: 37
A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 52
How prevalent is neobladder emptying failure, and how can it be treated?. Nature clinical practice. Urology. 2007 Comment GET IT
Urachal carcinoma: contemporary surgical outcomes. The Journal of urology. 2007 Academic Article GET IT
Times cited: 123
Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard. Seminars in oncology. 2007 Academic Article GET IT
Times cited: 14
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. The Journal of urology. 2007 Academic Article GET IT
Times cited: 132
Detection and management of isolated lymph node recurrence in patients with PSA relapse. European urology. 2007 Editorial Article GET IT
Times cited: 2
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology. 2007 Academic Article GET IT
Times cited: 60
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer gene therapy. 2007 Academic Article GET IT
Times cited: 30
Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder. Urologia internationalis. 2007 Academic Article GET IT
Times cited: 18
Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. International journal of urology : official journal of the Japanese Urological Association. 2007 Academic Article GET IT
Times cited: 57
Resection of recurrent cervical cancer after total pelvic exenteration. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2007 Academic Article GET IT
Times cited: 11
The use and abuse of data: nomograms and talking to patients about clinical medicine. Urologic oncology. 2007 Review GET IT
Times cited: 8
Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Review GET IT
Times cited: 84
Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?. Cancer. 2006 Academic Article GET IT
Times cited: 199
Importance of node dissection in relation to neoadjuvant and adjuvant therapy. Journal of the National Comprehensive Cancer Network : JNCCN. 2006 Review GET IT
Times cited: 1
Natural history of positive urinary cytology after radical cystectomy. The Journal of urology. 2006 Academic Article GET IT
Times cited: 20
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer. 2006 Academic Article GET IT
Times cited: 64
Use of nomograms as predictive tools in bladder cancer. World journal of urology. 2006 Review GET IT
Times cited: 12
Intravesical bacillus Calmette-Guérin combined with electromotive mitomycin for high-risk superficial bladder cancer. Nature clinical practice. Oncology. 2006 Editorial Article GET IT
Times cited: 3
Multimodal therapy for urologic cancers. Nature clinical practice. Urology. 2006 Editorial Article GET IT
Times cited: 1
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder. Cancer. 2006 Academic Article GET IT
Times cited: 312
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. The Journal of urology. 2006 Academic Article GET IT
Times cited: 47
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 377
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 151
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. The Journal of urology. 2006 Academic Article GET IT
Times cited: 6
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU international. 2006 Academic Article GET IT
Times cited: 46
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecologic oncology. 2005 Academic Article GET IT
Times cited: 136
Current status of establishing standards for lymphadenectomy in the treatment of bladder cancer. Current opinion in urology. 2005 Review GET IT
Times cited: 8
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma. The Journal of urology. 2005 Academic Article GET IT
Times cited: 23
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. The Journal of urology. 2005 Academic Article GET IT
Times cited: 56
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. The Journal of urology. 2004 Academic Article GET IT
Times cited: 84
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 193
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. The Journal of urology. 2004 Academic Article GET IT
Times cited: 176
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. The Journal of urology. 2004 Academic Article GET IT
Times cited: 114
Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 15
Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 32
Importance of lymph node dissection in urologic cancers. Urologic oncology. 2004 Academic Article GET IT
Umbilical endometriosis. 2003 GET IT
Times cited: 14
Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. The Urologic clinics of North America. 2003 Review GET IT
Times cited: 60
Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging. The Journal of urology. 2003 Academic Article GET IT
Times cited: 27
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. The Journal of urology. 2003 Academic Article GET IT
Times cited: 103
Tissue-specific transcriptional targeting of a replication-competent retroviral vector. Journal of virology. 2002 Academic Article GET IT
Times cited: 42
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 186
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. The Journal of urology. 2002 Academic Article GET IT
Times cited: 521
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. The Journal of urology. 2001 Academic Article GET IT
Times cited: 228
Development of lentiviral vectors for antiangiogenic gene delivery. Cancer gene therapy. 2001 Academic Article GET IT
Times cited: 51
Norepinephrine producing renal cell carcinoma. 2001 GET IT
Times cited: 1
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 2972
BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation. The Journal of urology. 2000 Academic Article GET IT
Times cited: 28
Endodermal sinus tumor of the vagina. 2000 GET IT
Times cited: 10
Clinical and pathologic significance of T1c adenocarcinoma of the prostate cancer. Prostate cancer and prostatic diseases. 1999 Academic Article GET IT
Genetic alterations in prostate cancer. The Journal of urology. 1999 Comment GET IT
Times cited: 1
Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate. American journal of clinical oncology. 1999 Academic Article GET IT
Times cited: 15
Extensive bladder and urethral calculi detected with computerized tomography: diagnosis and management. 1999 GET IT
Times cited: 4
Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate. Urology. 1999 Academic Article GET IT
Times cited: 25
An alternative ureteroileal reimplantation used in augmentation cystoplasty for neurogenic bladder with bilateral vesicoureteral reflux. 1998 GET IT
Times cited: 1
A serous lined antireflux valve: in vivo fluorourodynamic evaluation of antireflux continence mechanism. The Journal of urology. 1998 Academic Article GET IT
Times cited: 15
Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. The Journal of urology. 1998 Academic Article GET IT
Times cited: 92
The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique. The Journal of urology. 1998 Academic Article GET IT
Times cited: 119
Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 47
Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. Journal of the National Cancer Institute. 1997 Academic Article GET IT
Times cited: 299
Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. Journal of the National Cancer Institute. 1995 Academic Article GET IT
Times cited: 402
Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered? 1995 GET IT
Times cited: 12
Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder. 1995 GET IT
Times cited: 10
Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinoma. The Journal of surgical research. 1992 Academic Article GET IT
Times cited: 4
Interleukin-6 and renal cell cancer: production, regulation, and growth effects. Cancer immunology, immunotherapy : CII. 1992 Academic Article GET IT
Times cited: 105
[Adoptive immunotherapy and metastasized cancer of the kidney. Regulator effects of interleukin-4 on tumor infiltrating lymphocytes (TIL)]. Chirurgie; memoires de l'Academie de chirurgie. 1991 Academic Article GET IT
Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy. European urology. 1990 Academic Article GET IT
Times cited: 22

more ...

less ...

Background

education and training

M.D., University of California, Davis, School of Medicine 1990
B.S., University of Arizona 1985

Contact

full name

Bernard Bochner

VIVO Weill Cornell Medical College

Bernard Bochner Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name